Recon: Eli Lilly’s experimental obesity drug slashes weight in study; FDA approves first at-home device for depression
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States